标题
The oft-overlooked cardiovascular complications of inflammatory bowel disease
作者
关键词
-
出版物
Expert Review of Clinical Immunology
Volume -, Issue -, Pages -
出版商
Informa UK Limited
发表日期
2023-02-01
DOI
10.1080/1744666x.2023.2174971
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease
- (2022) Olga Iu. Mironova et al. TERAPEVTICHESKII ARKHIV
- Role of Butyrate, a Gut Microbiota Derived Metabolite, in Cardiovascular Diseases: A comprehensive narrative review
- (2022) Parichehr Amiri et al. Frontiers in Pharmacology
- Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis
- (2022) Jin Wang et al. Journal of the American Heart Association
- Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2022) Hao Wu et al. Journal of Clinical Medicine
- Increasing rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease: a nationwide analysis
- (2022) Adam S. Faye et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Inflammatory Bowel Disease Is Associated With an Increased Risk of Incident Acute Arterial Events: Analysis of the United Kingdom Biobank
- (2022) Quazim Alayo et al. Clinical Gastroenterology and Hepatology
- Mortality in patients with Inflammatory Bowel Disease: Results from 30 years of follow-up in a Norwegian inception cohort (the IBSEN study)
- (2022) Benoit Follin-Arbelet et al. Journal of Crohns & Colitis
- Overrepresentation of Enterobacteriaceae and Escherichia coli is the major gut microbiome signature in Crohn’s disease and ulcerative colitis; a comprehensive metagenomic analysis of IBDMDB datasets
- (2022) Babak Khorsand et al. Frontiers in Cellular and Infection Microbiology
- Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
- (2021) Séverine Vermeire et al. Journal of Crohns & Colitis
- Five-year Efficacy and Safety of Ustekinumab Treatment in Crohn’s Disease: the IM-UNITI trial
- (2021) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis
- (2021) Carlos Taxonera et al. INFLAMMATORY BOWEL DISEASES
- Persistently High Rate of Venous Thromboembolic Disease in Inflammatory Bowel Disease
- (2021) Charles N. Bernstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Premature Atherosclerotic Cardiovascular Disease Risk Among Patients with Inflammatory Bowel Disease
- (2021) Michelle T. Lee et al. AMERICAN JOURNAL OF MEDICINE
- Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular Disease
- (2021) Paul M Ridker et al. CIRCULATION RESEARCH
- Effectiveness and Safety of Ustekinumab in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2021) Sailish Honap et al. DIGESTIVE DISEASES AND SCIENCES
- VCAM-1 as a predictor biomarker in cardiovascular disease
- (2021) Mayarling Francisca Troncoso et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Antithrombotic Therapy for VTE Disease
- (2021) Scott M. Stevens et al. CHEST
- International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
- (2021) Pablo A. Olivera et al. Nature Reviews Gastroenterology & Hepatology
- Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases
- (2021) Jian-Hui Su et al. Frontiers in Pharmacology
- QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
- (2021) Marta Carrillo-Palau et al. Journal of Clinical Medicine
- Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
- (2021) Hua Zhang et al. Frontiers in Medicine
- Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
- (2021) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment
- (2021) Cong Wang et al. Frontiers in Pharmacology
- Risk for Cardiovascular Adverse Events Associated With Sphingosine-1-Phosphate Receptor Modulators in Patients With Multiple Sclerosis: Insights From a Pooled Analysis of 15 Randomised Controlled Trials
- (2021) Zhao Zhao et al. Frontiers in Immunology
- Atrial fibrillation in patients with inflammatory bowel disease: A systematic review and meta-analysis
- (2020) Marco Zuin et al. European Journal of Internal Medicine
- Safety of Janus Kinase Inhibitors in Patients with Inflammatory Bowel Diseases or Other Immune-mediated Diseases: a Systematic Review and Meta-Analysis
- (2020) Pablo Olivera et al. GASTROENTEROLOGY
- Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease
- (2020) William J. Sandborn et al. GASTROENTEROLOGY
- Ventricular Arrhythmias in Myocarditis
- (2020) Giovanni Peretto et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Therapeutic strategies for virus-negative myocarditis: a comprehensive review
- (2020) Giacomo De Luca et al. European Journal of Internal Medicine
- Long-term safety of approved biologics for ulcerative colitis
- (2020) Ferdinando D’Amico et al. Expert Opinion On Drug Safety
- Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease
- (2020) Parita Patel et al. INFLAMMATORY BOWEL DISEASES
- MYOCARDITIS COMPLICATING INFLAMMATORY BOWEL DISEASE: A COMPARISON BETWEEN ULCERATIVE COLITIS AND CROHN'S DISEASE FROM THE NATIONAL INPATIENT SAMPLE
- (2020) Shivaraj Patil et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Venous thromboembolism in inflammatory bowel disease
- (2020) Kimberly Cheng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Gut Microbiota and Cardiovascular Disease
- (2020) Marco Witkowski et al. CIRCULATION RESEARCH
- What gastroenterologists should know about direct oral anticoagulants
- (2020) F. Radaelli et al. DIGESTIVE AND LIVER DISEASE
- Inflammatory Bowel Disease and Acute Coronary Syndromes: From Pathogenesis to the Fine Line Between Bleeding and Ischemic Risk
- (2020) Martino Pepe et al. INFLAMMATORY BOWEL DISEASES
- Cytokines in inflammatory bowel diseases – Update 2020
- (2020) M. Leppkes et al. PHARMACOLOGICAL RESEARCH
- Prevalence and Effect of Genetic Risk of Thrombo-embolic Disease in Inflammatory Bowel Disease.
- (2020) Takeo Naito et al. GASTROENTEROLOGY
- Inflammation as a Predictor of Recurrent Ventricular Tachycardia After Ablation in Patients With Myocarditis
- (2020) Giovanni Peretto et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-based Data
- (2019) Stephanie Coward et al. GASTROENTEROLOGY
- AZATHIOPRINE-INDUCED ACUTE FULMINANT EOSINOPHILIC MYOCARDITIS
- (2019) Terence Sean Dunn et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease
- (2019) Jeffrey D. McCurdy et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of Janus kinase inhibitors on risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials
- (2019) Wenhui Xie et al. ANNALS OF THE RHEUMATIC DISEASES
- Acute Venous Thromboembolism Risk Highest Within 60 Days After Discharge From the Hospital in Patients With Inflammatory Bowel Diseases
- (2019) Adam S. Faye et al. Clinical Gastroenterology and Hepatology
- Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease
- (2019) Elena Ferrer-Picón et al. INFLAMMATORY BOWEL DISEASES
- Inflammatory Bowel Disease Increases Risk of Type 2 Diabetes in a Nationwide Cohort Study
- (2019) Tine Jess et al. Clinical Gastroenterology and Hepatology
- Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study
- (2019) Julien Kirchgesner et al. GUT
- The Safety Profile of Vedolizumab in Ulcerative Colitis and Crohn’s Disease: 4 Years of Global Post-Marketing Data
- (2019) Russell D Cohen et al. Journal of Crohns & Colitis
- Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
- (2019) Bruce E. Sands et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
- (2019) Israr Khan et al. Pathogens
- Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme
- (2019) William J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients with Ulcerative Colitis
- (2019) William J. Sandborn et al. GASTROENTEROLOGY
- Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients
- (2019) Iris Detrez et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Microbiota-derived peptide mimics drive lethal inflammatory cardiomyopathy
- (2019) Cristina Gil-Cruz et al. SCIENCE
- Systematic review: safety of mesalazine in ulcerative colitis
- (2018) P. Sehgal et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- The American Society of Colon and Rectal Surgeons Clinical Practice Guideline for the Prevention of Venous Thromboembolic Disease in Colorectal Surgery
- (2018) Fergal Fleming et al. DISEASES OF THE COLON & RECTUM
- Heart Under Attack: Cardiac Manifestations of Inflammatory Bowel Disease
- (2018) Natalie E Mitchell et al. INFLAMMATORY BOWEL DISEASES
- Infliximab for Crohn’s Disease: More Than 13 Years of Real-world Experience
- (2018) Gary R Lichtenstein et al. INFLAMMATORY BOWEL DISEASES
- Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial
- (2018) Mark C Genovese et al. LANCET
- Inflammatory bowel disease and cardiovascular disease incidence and mortality: A meta-analysis
- (2018) Hong-Hao Sun et al. European Journal of Preventive Cardiology
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
- (2018) AMERICAN JOURNAL OF GASTROENTEROLOGY
- Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
- (2018) William J. Sandborn et al. Clinical Gastroenterology and Hepatology
- Impact of systemic immune-mediated diseases on clinical features and prognosis of patients with biopsy-proved myocarditis
- (2018) Giovanni Peretto et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Incidence of Cardiovascular Events in Patients with Crohn’s Disease Treated with Vedolizumab and Anti-TNF Therapies
- (2017) Raymond K. Cross et al. GASTROENTEROLOGY
- Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study
- (2017) Julien Kirchgesner et al. GUT
- P448 Biologic therapy and immunodulators are associated with decreased risk of cardiovascular events in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis
- (2017) M. Fumery et al. Journal of Crohns & Colitis
- P705 Peripheral arterial disease is associated with an increased risk of elderly-onset inflammatory bowel disease
- (2017) F. Peerani et al. Journal of Crohns & Colitis
- Steroid but not Biological Therapy Elevates the risk of Venous Thromboembolic Events in Inflammatory Bowel Disease: A Meta-Analysis
- (2017) Patricia Sarlos et al. Journal of Crohns & Colitis
- Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
- (2017) Séverine Vermeire et al. LANCET
- Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
- (2017) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience
- (2017) Fabio Salvatore Macaluso et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The gut microbiome in atherosclerotic cardiovascular disease
- (2017) Zhuye Jie et al. Nature Communications
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
- (2017) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
- (2017) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Inflammatory Bowel Disease and Risk of Ischemic Heart Disease: An Updated Meta‐Analysis of Cohort Studies
- (2017) Wan Feng et al. Journal of the American Heart Association
- Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
- (2017) Giulio Cavalli et al. Frontiers in Immunology
- The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium
- (2016) Parambir S Dulai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Treating Life-Threatening Myocarditis by Blocking Interleukin-1*
- (2016) Giulio Cavalli et al. CRITICAL CARE MEDICINE
- Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis
- (2016) Pietro Enea Lazzerini et al. EUROPEAN HEART JOURNAL
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Antitumor Necrosis Factor-α Therapy Is Associated With Reduced Risk of Thromboembolic Events in Hospitalized Patients With Inflammatory Bowel Disease
- (2016) Arushi M. deFonseka et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Endothelial dysfunction in inflammatory bowel diseases: Pathogenesis, assessment and implications
- (2016) Dorota Cibor WORLD JOURNAL OF GASTROENTEROLOGY
- Corticosteroid Use and Complications in a US Inflammatory Bowel Disease Cohort
- (2016) Akbar K. Waljee et al. PLoS One
- Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis
- (2015) P. C. Lunney et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study
- (2015) L. Fernandez-Friera et al. CIRCULATION
- Increased Risk of Venous Thromboembolic Events With Corticosteroid vs Biologic Therapy for Inflammatory Bowel Disease
- (2015) Peter D.R. Higgins et al. Clinical Gastroenterology and Hepatology
- Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis
- (2015) Adnan M. Subei et al. CNS DRUGS
- Adverse effects of glucocorticoids: coagulopathy
- (2015) Maria Caroline Alves Coelho et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Short-term Effect of Infliximab Is Reflected in the Clot Lysis Profile of Patients with Inflammatory Bowel Disease
- (2015) Lize Bollen et al. INFLAMMATORY BOWEL DISEASES
- The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
- (2015) Marcus Harbord et al. Journal of Crohns & Colitis
- Inflammatory Bowel Disease Increases the Risk of Peripheral Arterial Disease
- (2015) Te-Yu Lin et al. MEDICINE
- Management of a Patient With Eosinophilic Myocarditis and Normal Peripheral Eosinophil Count
- (2014) Thierry Fozing et al. Circulation-Heart Failure
- Inflammatory Bowel Disease Is Associated With an Increased Risk of Hospitalization for Heart Failure
- (2014) Søren Lund Kristensen et al. Circulation-Heart Failure
- Thromboprophylaxis Is Associated With Reduced Post-hospitalization Venous Thromboembolic Events in Patients With Inflammatory Bowel Diseases
- (2014) Ashwin N. Ananthakrishnan et al. Clinical Gastroenterology and Hepatology
- Targeting Platelet-Neutrophil Interactions in Giant-Cell Arteritis
- (2014) Mattia Baldini et al. CURRENT PHARMACEUTICAL DESIGN
- Rate and patient features associated with recurrence of acute myocarditis
- (2014) Ville Kytö et al. European Journal of Internal Medicine
- Consensus Statements on the Risk, Prevention, and Treatment of Venous Thromboembolism in Inflammatory Bowel Disease: Canadian Association of Gastroenterology
- (2014) Geoffrey C. Nguyen et al. GASTROENTEROLOGY
- Fingolimod in relapsing multiple sclerosis: An integrated analysis of safety findings
- (2014) Ludwig Kappos et al. Multiple Sclerosis and Related Disorders
- Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study*
- (2013) Iain B McInnes et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained Clinical Benefit and Tolerability of Methotrexate Monotherapy After Thiopurine Therapy in Patients With Crohn's Disease
- (2013) Margien L. Seinen et al. Clinical Gastroenterology and Hepatology
- Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study
- (2013) S. L. Kristensen et al. EUROPACE
- Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
- (2013) A. L. P. Caforio et al. EUROPEAN HEART JOURNAL
- A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitis
- (2013) Kathleen Machiels et al. GUT
- Safety of Thiopurine Therapy in Inflammatory Bowel Disease
- (2013) María Chaparro et al. INFLAMMATORY BOWEL DISEASES
- Genetics of Human Cardiovascular Disease
- (2012) Sekar Kathiresan et al. CELL
- Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study
- (2012) Christine Rungoe et al. GUT
- Clinical presentation of venous thromboembolism in inflammatory bowel disease
- (2012) Pavol Papay et al. Journal of Crohns & Colitis
- Changes of the cytokine profile in inflammatory bowel diseases
- (2012) Györgyi Műzes WORLD JOURNAL OF GASTROENTEROLOGY
- Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
- (2011) Warren Strober et al. GASTROENTEROLOGY
- Single-nucleotide polymorphisms in inflammatory bowel disease
- (2011) Manuela G. Neuman et al. Translational Research
- 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary
- (2010) et al. CIRCULATION
- Myocarditis associated with infliximab
- (2010) Eoin Slattery et al. INFLAMMATORY BOWEL DISEASES
- Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study
- (2010) Matthew J Grainge et al. LANCET
- Risk of ischemic stroke in patients with Crohnʼs disease
- (2009) Frank Andersohn et al. INFLAMMATORY BOWEL DISEASES
- Rising Prevalence of Venous Thromboembolism and Its Impact on Mortality Among Hospitalized Inflammatory Bowel Disease Patients
- (2008) Geoffrey C. Nguyen et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started